Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine
Tarih
2011Yazar
BİLGİNER, YELDA
Ayaz, Nuray
Calguneri, Meral
ÖZEN, SEZA
Üst veri
Tüm öğe kaydını gösterÖzet
Objective. Familial Mediterranean fever (FMF) is a recessively inherited autoinflammatory disorder characterized by recurrent attacks of fever and serositis. Although colchicine is the standard therapy for preventing attacks and suppressing inflammation, 5%-10% of compliant patients are colchicine-resistant. We report the effect of anti-tumor necrosis factor therapy (etanercept) and anti-interleukin 1 (IL-1) treatment (anakinra) in 6 cases resistant to colchicine therapy.
Koleksiyonlar
- Makale [92796]